2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Hurst Stephen L | — | 40,722,778 | Jan 10, 2022 |
| Barrow Robert | CEO | 804,268 | Sep 26, 2025 |
| Karlin Daniel | Chief Medical Officer | 430,625 | Sep 26, 2025 |
| Sullivan Mark | Chief Legal Officer | 293,852 | Sep 26, 2025 |
| Greenway Schond L. | CFO | 211,057 | Mar 26, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Feb 5, 2026 | Wiley Matthew T. | Chief Commercial Officer | Neutral | 90.0 | +115,000 | 100.00% | ✗ | - |
| Feb 3, 2026 | Feb 5, 2026 | Roberts Brandi | CFO | Neutral | 90.0 | +150,000 | 100.00% | ✗ | - |
| Feb 3, 2026 | Feb 5, 2026 | Sullivan Mark | Chief Legal Officer | Neutral | 90.0 | +125,000 | 44.24% | ✗ | - |
| Feb 3, 2026 | Feb 5, 2026 | Karlin Daniel | Chief Medical Officer | Neutral | 90.0 | +150,000 | 35.29% | ✗ | - |
| Feb 3, 2026 | Feb 5, 2026 | Barrow Robert | CEO | Neutral | 90.0 | +320,000 | 41.11% | ✗ | - |
| Jan 29, 2026 | Jan 29, 2026 | Adsett Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 29, 2026 | Adsett Roger | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 26, 2025 | Dec 29, 2025 | Karlin Daniel | Chief Medical Officer | Sell | 46.3 | -5,600 | -1.30% | ✓ | $73.6K |
| Dec 26, 2025 | Dec 29, 2025 | Barrow Robert | CEO | Sell | 37.5 | -25,791 | -3.21% | ✓ | $339.1K |
| Dec 26, 2025 | Dec 29, 2025 | Sullivan Mark | Chief Legal Officer | Sell | 38.8 | -11,276 | -3.84% | ✓ | $148.2K |
| Sep 25, 2025 | Sep 26, 2025 | Sullivan Mark | Chief Legal Officer | Sell | 37.5 | -11,278 | -3.70% | ✓ | $110.2K |
| Sep 25, 2025 | Sep 26, 2025 | Barrow Robert | CEO | Sell | 35.0 | -25,797 | -3.11% | ✓ | $252K |
| Sep 25, 2025 | Sep 26, 2025 | Karlin Daniel | Chief Medical Officer | Sell | 45.0 | -7,704 | -1.76% | ✓ | $75.3K |
| Jun 25, 2025 | Jun 26, 2025 | Sullivan Mark | Chief Legal Officer | Sell | 37.5 | -11,491 | -3.63% | ✓ | $78.1K |
| Jun 25, 2025 | Jun 26, 2025 | Karlin Daniel | Chief Medical Officer | Sell | 45.0 | -7,848 | -1.76% | ✓ | $53.4K |
| Jun 25, 2025 | Jun 26, 2025 | Barrow Robert | CEO | Sell | 37.5 | -26,491 | -3.09% | ✓ | $180.1K |
| Jun 12, 2025 | Jun 16, 2025 | Krebs Andreas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2025 | Jun 16, 2025 | Vallone Carol A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2025 | Jun 16, 2025 | Bruhn Suzanne Louise | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2025 | Jun 16, 2025 | CRYSTAL ROGER | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2025 | Jun 16, 2025 | GRYSKA DAVID W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2025 | Jun 2, 2025 | Roberts Brandi | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 2, 2025 | Roberts Brandi | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 25, 2025 | Mar 26, 2025 | Barrow Robert | CEO | Sell | 41.3 | -21,208 | -2.42% | ✓ | $142.9K |
| Mar 25, 2025 | Mar 26, 2025 | Karlin Daniel | Chief Medical Officer | Sell | 48.8 | -6,836 | -1.51% | ✓ | $46.1K |
| Mar 25, 2025 | Mar 26, 2025 | Sullivan Mark | Chief Legal Officer | Sell | 45.0 | -6,576 | -2.03% | ✓ | $44.3K |
| Mar 25, 2025 | Mar 26, 2025 | Liao Carrie | Chief Accounting Officer | Sell | 48.8 | -2,347 | -1.59% | ✓ | $15.8K |
| Mar 17, 2025 | Mar 18, 2025 | Wiley Matthew T. | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 18, 2025 | Wiley Matthew T. | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 12, 2025 | Mar 13, 2025 | Barrow Robert | CEO | Neutral | 90.0 | +350,000 | 66.32% | ✗ | - |
| Mar 12, 2025 | Mar 13, 2025 | Karlin Daniel | Chief Medical Officer | Neutral | 90.0 | +115,000 | 34.02% | ✗ | - |
| Mar 12, 2025 | Mar 13, 2025 | Sullivan Mark | Chief Legal Officer | Neutral | 90.0 | +150,000 | 86.61% | ✗ | - |
| Mar 12, 2025 | Mar 13, 2025 | Liao Carrie | Chief Accounting Officer | Neutral | 90.0 | +50,000 | 54.19% | ✗ | - |
| Dec 26, 2024 | Dec 27, 2024 | Barrow Robert | CEO | Sell | 37.5 | -19,106 | -3.50% | ✓ | $142K |
| Dec 26, 2024 | Dec 27, 2024 | Liao Carrie | Chief Accounting Officer | Sell | 45.0 | -2,273 | -2.28% | ✓ | $16.9K |
| Dec 26, 2024 | Dec 27, 2024 | Karlin Dan | Chief Medical Officer | Sell | 48.8 | -6,643 | -1.93% | ✓ | $49.4K |
| Dec 26, 2024 | Dec 27, 2024 | Sullivan Mark | Chief Legal Officer | Sell | 45.0 | -4,519 | -2.54% | ✓ | $33.6K |
| Dec 5, 2024 | Dec 5, 2024 | GRYSKA DAVID W | Director | Buy | 91.3 | +2,500 | 14.41% | ✗ | $17.9K |
| Sep 25, 2024 | Sep 25, 2024 | Liao Carrie | Chief Accounting Officer | Sell | 45.0 | -2,352 | -2.31% | ✓ | $14.1K |
| Sep 25, 2024 | Sep 25, 2024 | Barrow Robert | CEO | Sell | 37.5 | -19,771 | -3.50% | ✓ | $118.2K |
| Sep 25, 2024 | Sep 25, 2024 | Karlin Dan | Chief Medical Officer | Sell | 48.8 | -6,871 | -1.95% | ✓ | $41.1K |
| Sep 25, 2024 | Sep 25, 2024 | Sullivan Mark | Chief Legal Officer | Sell | 45.0 | -4,430 | -2.43% | ✓ | $26.5K |
| Aug 23, 2024 | Aug 26, 2024 | GRYSKA DAVID W | Director | Buy | 91.3 | +3,500 | 25.27% | ✗ | $20.9K |
| Aug 21, 2024 | Aug 22, 2024 | Halperin Wernli Miri | President | Sell | 42.5 | -32,595 | -13.87% | ✗ | $201.1K |
| Aug 19, 2024 | Aug 20, 2024 | Barrow Robert | CEO | Buy | 55.0 | +1,000 | 0.18% | ✗ | $6.2K |
| Jun 25, 2024 | Jun 25, 2024 | Karlin Dan | Chief Medical Officer | Sell | 48.8 | -6,925 | -1.93% | ✓ | $50K |
| Jun 25, 2024 | Jun 25, 2024 | Sullivan Mark | Chief Legal Officer | Sell | 28.8 | -17,854 | -8.93% | ✓ | $128.9K |
| Jun 25, 2024 | Jun 25, 2024 | Barrow Robert | CEO | Sell | 41.3 | -15,659 | -2.70% | ✓ | $113.1K |
| Jun 10, 2024 | Jun 12, 2024 | Vallone Carol A | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 12, 2024 | GRYSKA DAVID W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 12, 2024 | CRYSTAL ROGER | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 12, 2024 | Bruhn Suzanne Louise | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 10, 2024 | Jun 12, 2024 | Krebs Andreas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 25, 2024 | Mar 26, 2024 | Greenway Schond L. | CFO | Sell | 42.5 | -5,560 | -2.57% | ✗ | $54.4K |
| Mar 25, 2024 | Mar 26, 2024 | Karlin Dan | Chief Medical Officer | Sell | 45.0 | -6,578 | -1.80% | ✓ | $62.5K |
| Mar 25, 2024 | Mar 26, 2024 | Barrow Robert | CEO | Sell | 41.3 | -16,519 | -2.77% | ✓ | $156.9K |
| Feb 27, 2024 | Feb 29, 2024 | Wernli Miri Halperin | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 27, 2024 | Feb 29, 2024 | Greenway Schond L. | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 27, 2024 | Feb 29, 2024 | Sullivan Mark | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 27, 2024 | Feb 29, 2024 | Karlin Dan | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 27, 2024 | Feb 29, 2024 | Liao Carrie | Chief Accounting Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 27, 2024 | Feb 29, 2024 | Barrow Robert | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 26, 2023 | Dec 26, 2023 | Karlin Dan | Chief Medical Officer | Sell | 46.3 | -6,774 | -1.82% | ✗ | $24.6K |
| Dec 26, 2023 | Dec 26, 2023 | Barrow Robert | CEO | Sell | 46.3 | -13,237 | -2.17% | ✗ | $48.1K |
| Dec 26, 2023 | Dec 26, 2023 | Greenway Schond L. | CFO | Sell | 46.3 | -5,652 | -2.54% | ✗ | $20.5K |
| Sep 25, 2023 | Sep 25, 2023 | Barrow Robert | CEO | Sell | 46.3 | -13,499 | -2.16% | ✗ | $48.3K |
| Sep 25, 2023 | Sep 25, 2023 | Karlin Dan | Chief Medical Officer | Sell | 46.3 | -6,918 | -1.83% | ✗ | $24.7K |
| Sep 25, 2023 | Sep 25, 2023 | Greenway Schond L. | CFO | Sell | 46.3 | -5,762 | -2.53% | ✗ | $20.6K |
| Aug 25, 2023 | Aug 28, 2023 | Greenway Schond L. | CFO | Sell | 22.5 | -20,000 | -8.06% | ✗ | $76K |
| Jun 27, 2023 | Jun 27, 2023 | Barrow Robert | CEO | Sell | 46.3 | -15,502 | -2.43% | ✗ | $49.6K |
| Jun 27, 2023 | Jun 27, 2023 | Karlin Dan | Chief Medical Officer | Sell | 46.3 | -6,783 | -1.76% | ✗ | $21.7K |
| Jun 27, 2023 | Jun 27, 2023 | Greenway Schond L. | CFO | Sell | 46.3 | -11,635 | -4.48% | ✗ | $37.2K |
| Jun 21, 2023 | Jun 23, 2023 | GRYSKA DAVID W | Director | Neutral | 90.0 | +13,851 | 100.00% | ✗ | - |
| Jun 21, 2023 | Jun 23, 2023 | CRYSTAL ROGER | Director | Neutral | 90.0 | +13,671 | 229.69% | ✗ | - |
| Jun 21, 2023 | Jun 23, 2023 | Krebs Andreas | Director | Neutral | 90.0 | +13,671 | 952.02% | ✗ | - |
| Jun 21, 2023 | Jun 23, 2023 | Vallone Carol A | Director | Neutral | 90.0 | +13,671 | 475.84% | ✗ | - |
| Jun 21, 2023 | Jun 23, 2023 | Bruhn Suzanne Louise | Director | Neutral | 90.0 | +13,671 | 229.69% | ✗ | - |
| Jun 23, 2023 | GRYSKA DAVID W | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 14, 2023 | Apr 24, 2023 | Greenway Schond L. | CFO | Neutral | 90.0 | +175,000 | 206.69% | ✗ | - |
| Mar 14, 2023 | Apr 24, 2023 | Wernli Miri Halperin | President | Neutral | 90.0 | +100,000 | 117.65% | ✗ | - |
| Mar 14, 2023 | Apr 24, 2023 | Liao Carrie | Chief Accounting Officer | Neutral | 90.0 | +75,000 | 278.86% | ✗ | - |
| Apr 13, 2023 | Apr 14, 2023 | Sullivan Mark | Chief Legal Officer | Neutral | 90.0 | +200,000 | 100.00% | ✗ | - |
| Apr 14, 2023 | Sullivan Mark | Chief Legal Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 14, 2023 | Mar 17, 2023 | Barrow Robert | CEO | Neutral | 90.0 | +400,000 | 167.39% | ✗ | - |
| Mar 14, 2023 | Mar 17, 2023 | Liao Carrie | VP, Controller&Acct Principal | Neutral | 90.0 | +75,000 | 18.59% | ✗ | - |
| Mar 14, 2023 | Mar 17, 2023 | Karlin Dan | Chief Medical Officer | Neutral | 90.0 | +125,000 | 47.98% | ✗ | - |
| Mar 14, 2023 | Mar 17, 2023 | Wernli Miri Halperin | President | Neutral | 85.0 | +100,000 | 7.84% | ✗ | - |
| Mar 14, 2023 | Mar 17, 2023 | Greenway Schond L. | CFO | Neutral | 90.0 | +175,000 | 13.78% | ✗ | - |
| Mar 1, 2023 | Mar 2, 2023 | Karlin Dan | Chief Medical Officer | Sell | 46.3 | -3,577 | -1.35% | ✗ | $12.6K |
| Mar 1, 2023 | Mar 2, 2023 | Barrow Robert | CEO | Sell | 46.3 | -8,273 | -3.35% | ✗ | $29K |
| Dec 21, 2022 | Dec 22, 2022 | Barrow Robert | CEO | Sell | 46.3 | -3,861 | -1.54% | ✗ | $10.4K |
| Dec 21, 2022 | Dec 22, 2022 | Karlin Dan | Chief Medical Officer | Sell | 52.5 | -1,211 | -0.46% | ✗ | $3.3K |
| Oct 25, 2022 | Oct 27, 2022 | Karlin Dan | Chief Medical Officer | Sell | 52.5 | -1,185 | -0.44% | ✗ | $3.5K |
| Oct 25, 2022 | Oct 25, 2022 | Barrow Robert | CEO | Sell | 52.5 | -1,207 | -0.48% | ✗ | $3.4K |
| Oct 18, 2022 | Oct 18, 2022 | Barrow Robert | CEO | Sell | 52.5 | -1,220 | -0.48% | ✗ | $3.8K |
| Sep 26, 2022 | Sep 27, 2022 | Karlin Dan | Chief Medical Officer | Sell | 52.5 | -1,205 | -0.45% | ✗ | $6.9K |
| Sep 26, 2022 | Sep 27, 2022 | Barrow Robert | CEO | Sell | 52.5 | -1,264 | -0.50% | ✗ | $7K |
| Sep 16, 2022 | Sep 19, 2022 | Barrow Robert | CEO | Sell | 50.0 | -1,350 | -0.53% | ✗ | $9.8K |
| Aug 31, 2022 | Sep 1, 2022 | Karlin Dan | Chief Medical Officer | Sell | 51.3 | -1,204 | -0.45% | ✗ | $14.1K |
| Aug 31, 2022 | Sep 1, 2022 | Barrow Robert | CEO | Sell | 51.3 | -1,228 | -0.48% | ✗ | $14.3K |